2Espinal MA, Laserson K, Camacho M,et al.Determinants of drug-resistant tuberculosis:analysis of 11 countries.Int J Tuberc Lung Dis, 2001,5:887-893.
3World Health Organization, International Union Against Tuberculosis and Lung Disease.Anti-tuberculosis drug resistance in the world: the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance: Report No.2.Prevalence and Trends.Geneva:
4Taylor JP, Bergmire-Sweat D, Suarez L.Epidemiology of drug-resistant tuberculosis in Texas.Am J Epidemiol,1999,149:359-365.
5Raviglione MC, Gupta R, Dye CM, et al.The burden of drug-resistant tuberculosis and mechanisms for its control.Ann N Y Acad Sci, 2001, 953:88-97.
6Drobniewski FA, Wilson SM.The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosis-a molecular story.J Med Microbiol, 1998, 47:189-196.
7Espinal MA, Kim SJ, Suarez PG, et al.Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcome in six countries.JAMA, 2000,283:2537-2545.
8Drobniewski FA, Walterson SA,Wilson SM, et al.A clinical, microbiological and economic analysis of a national service for the rapid molecular diagnosis of tuberculosis and rifampincin resistance in Mycobacterium tuberculosis.J Med Microbiol, 2000,49:271-2
9Garcia-Garcia ML, Ponce-de-Leon A, Jimenez-Corona ME, et al.Clinical consequences and transmissibility of drug-resistant tuberculosis in Southern Mexico.Arch Intern Med, 2000,160:630-636.
10Mitchison DA.How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.Int J Tuberc Lung Dis, 1998,2:10-15.
